The broadest mission of these Conferences is the collective pursuit of understanding of the issues surrounding early diagnosis of lung cancer. While the main focus has been on the development and evaluation of the regimen of early diagnosis of lung cancer, a secondary focus has been on the diagnosis of other chest diseases in the context of screening for lung cancer.
The 21st Conference will present the new affiliation of I-ELCAP with the BioDesign Institute of Arizona State University including its resources and planned interactions. This Conference will focus on new frontiers in staging, pathology, imaging technology and treatment of early lung cancer as well as other related diseases. It will also present advances in the I-ELCAP infrastructure that will allow it to participate in large scale diagnostic and therapeutic studies. Eminent questions of how to optimize and evaluate the regimen of screening will be addressed.